Selskabets formål er at drive handel og industri samt finansiering og investering.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 348.3 mio. | 2.9 mio. | 103.7 mio. | 44.4 mio. | 53 | |
CVR: 26991064
Secondary names: BRØSTE A/S, AZELIS NORDIC HOLDING A/S, AZELIS NORDIC A/S
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Basak Vural joined the board
Thijs William Bakker left the board
Lise Viby Fursund joined the board
Lise Viby Fursund joined as ADM. DIR.
Gert Allan Schnoor left the board
Gert Allan Schnoor left as ADM. DIR.
Beierholm Godkendt Revisionspartnerselskab appointed as auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB resigned as auditor
Companies in the same industry and area
CVR 13911932
CVR 27066577
CVR 21829072
CVR 40652337
CVR 41344709
Compared to 181 companies in Engroshandel med kemiske produkter
Comparison is based on industry median values
Azelis Denmark A/S exhibits a fluctuating financial performance, with revenue peaking at 472 million DKK in 2022 before declining to 348 million DKK in 2025. Profitability has also varied significantly, with a notable drop from 16.6 million DKK in 2024 to just 2.9 million DKK in 2025, indicating potential challenges in maintaining margins. The company's equity position has seen some volatility, decreasing from 60.2 million DKK in 2024 to 44.4 million DKK in 2025, raising concerns about financial stability. Overall, while Azelis Denmark operates within the chemical products wholesale industry, its recent financial trajectory suggests a need for strategic adjustments to enhance profitability and equity resilience.
AI-generated summary
companydata.dk